No abstract available
MeSH terms
-
Antiviral Agents / administration & dosage
-
Antiviral Agents / therapeutic use*
-
Clinical Trials, Phase III as Topic / methods
-
Drug Approval / methods*
-
Drug Monitoring / methods*
-
Drug Resistance, Viral
-
Drug Therapy, Combination / standards
-
Evidence-Based Medicine / methods
-
Hepatitis C, Chronic / drug therapy*
-
Humans
-
Interferon-alpha / therapeutic use
-
Proline / administration & dosage
-
Proline / analogs & derivatives*
-
Proline / therapeutic use
-
Ribavirin / therapeutic use
-
United States
Substances
-
Antiviral Agents
-
Interferon-alpha
-
Ribavirin
-
N-(3-amino-1-(cyclobutylmethyl)-2,3-dioxopropyl)-3-(2-((((1,1-dimethylethyl)amino)carbonyl)amino)-3,3-dimethyl-1-oxobutyl)-6,6-dimethyl-3-azabicyclo(3.1.0)hexan-2-carboxamide
-
Proline